Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Zibelman M, MacFarlane AW 4th, Costello K, McGowan T, O'Neill J, Kokate R, Borghaei H, Denlinger CS, Dotan E, Geynisman DM, Jain A, Martin L, Obeid E, Devarajan K, Ruth K, Alpaugh RK, Dulaimi EA, Cukierman E, Einarson M, Campbell KS, Plimack ER. Zibelman M, et al. Among authors: einarson m. Nat Commun. 2023 Jul 27;14(1):4513. doi: 10.1038/s41467-023-40028-z. Nat Commun. 2023. PMID: 37500647 Free PMC article. Clinical Trial.
Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer.
Ward WH, Meeker CR, Handorf E, Hill MV, Einarson M, Alpaugh RK, Holden TL, Astsaturov I, Denlinger CS, Hall MJ, Reddy SS, Sigurdson ER, Dotan E, Zibelman M, Meyer JE, Farma JM, Vijayvergia N. Ward WH, et al. Among authors: einarson m. JCO Clin Cancer Inform. 2021 Jan;5:125-133. doi: 10.1200/CCI.20.00117. JCO Clin Cancer Inform. 2021. PMID: 33492994 Free PMC article.
Synthetic lethal screen of an EGFR-centered network to improve targeted therapies.
Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA. Astsaturov I, et al. Among authors: einarson mb. Sci Signal. 2010 Sep 21;3(140):ra67. doi: 10.1126/scisignal.2001083. Sci Signal. 2010. PMID: 20858866 Free PMC article.
Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.
Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A, Einarson MB, Zhou Y, Braiman A, Campbell KS, Porgador A. Brusilovsky M, et al. Among authors: einarson mb. J Immunol. 2013 Nov 15;191(10):5256-67. doi: 10.4049/jimmunol.1302079. Epub 2013 Oct 14. J Immunol. 2013. PMID: 24127555 Free PMC article.
Correction to: Thymine DNA glycosylase as a novel target for melanoma.
Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J, Nicolas E, Einarson M, Beeharry N, Devarajan K, Katz RA, Dorjsuren DG, Sun H, Simeonov A, Giordano A, Testa JR, Davidson G, Davidson I, Larue L, Sobol RW, Yen TJ, Bellacosa A. Mancuso P, et al. Among authors: einarson m. Oncogene. 2022 Jun;41(23):3300-3301. doi: 10.1038/s41388-022-02335-5. Oncogene. 2022. PMID: 35505094 No abstract available.
Thymine DNA glycosylase as a novel target for melanoma.
Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J, Nicolas E, Einarson M, Beeharry N, Devarajan K, Katz RA, Dorjsuren DG, Sun H, Simeonov A, Giordano A, Testa JR, Davidson G, Davidson I, Larue L, Sobol RW, Yen TJ, Bellacosa A. Mancuso P, et al. Among authors: einarson m. Oncogene. 2019 May;38(19):3710-3728. doi: 10.1038/s41388-018-0640-2. Epub 2019 Jan 23. Oncogene. 2019. PMID: 30674989 Free PMC article.
52 results